310 related articles for article (PubMed ID: 30055585)
1. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
3. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
5. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
[TBL] [Abstract][Full Text] [Related]
6. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
7. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
[TBL] [Abstract][Full Text] [Related]
8. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
9. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
[No Abstract] [Full Text] [Related]
10. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
[TBL] [Abstract][Full Text] [Related]
11. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
13. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
[TBL] [Abstract][Full Text] [Related]
14. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
15. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
16. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
17. The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
Bar D; Lavie O; Stein N; Feferkorn I; Shai A
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():227-231. PubMed ID: 27890326
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
19. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
20. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.
Urpilainen E; Arima R; Karihtala P; Puistola U; Ahtikoski A
Anticancer Res; 2021 Feb; 41(2):821-828. PubMed ID: 33517287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
